Cigniti Technologies Q4 FY26 board meet on May 5

Board meeting set for May 5, 2026

Cigniti Technologies has scheduled a meeting of its Board of Directors on May 5, 2026 to consider its Q4 FY26 financial results. The update puts the company back in focus for investors tracking earnings season and management commentary. Board meetings for results typically act as the formal point at which audited or limited-review numbers are placed before the board for approval. For market participants, the date also anchors timelines for official disclosures to stock exchanges. The company has previously followed the standard practice of restricting trading by designated persons around results. The May 5 meeting therefore becomes a key near-term event for shareholders looking for clarity on the quarter’s operational momentum.

Trading window practice around results

Cigniti has repeatedly communicated trading-window closures around financial results in line with SEBI (Prohibition of Insider Trading) Regulations, 2015. For example, it had informed that the trading window would remain closed from October 1, 2025 and reopen 48 hours after declaring results for the quarter and half-year ended September 30, 2025. A similar closure was communicated from July 1, 2025 for the quarter ended June 30, 2025, with reopening after 48 hours of public declaration. For Q3 results, Cigniti announced a board meeting on January 22, 2026 to approve financial results, along with a trading-window closure from January 1, 2026 until 48 hours after the declaration. These disclosures indicate the company’s consistent approach to compliance-driven blackout periods.

What the market already knows from FY2025

Cigniti’s previously reported Q4 FY2025 performance included a quarter-on-quarter increase in net profit to ₹731.50 crore from ₹636.00 crore in Q3. It also reported full-year revenue growth of 11% to ₹20,143.41 crore, while net profit rose 20.9% to ₹2,001.74 crore. The company said it delivered strong operating profit and cash flow during the period. Separately, another reported summary described Q4 FY2025 as showing consolidated revenue up 16.38% year-on-year to ₹5,302.77 crore and net profit up 169.57% year-on-year to ₹731.50 crore. Since multiple summaries cite different bases and comparisons, investors typically rely on the stock exchange filing for the definitive set of numbers and definitions.

Merger with Coforge: a key corporate development

A major corporate action referenced alongside FY2025 results was the board’s approval of a merger with Coforge Limited. The same update noted that Coforge acquired a 54% stake in Cigniti during the fiscal year. This is a material development because it changes the strategic context in which quarterly results are read, including potential integration costs, one-offs, or accounting impacts depending on the stage and structure of the transaction. For investors, upcoming results periods often become checkpoints for any merger-related progress updates. The May 5, 2026 board meeting for Q4 FY26 results is therefore expected to be watched not only for earnings but also for any formal updates the company may provide in its filing.

Standalone snapshot: December 2025 quarter (reported)

The article data also includes reported standalone quarterly numbers for the quarter ended December 2025. Net sales (income from operations) were reported at ₹392.80 crore in December 2025, up 45.25% from ₹270.44 crore in December 2024. Standalone net profit for December 2025 was reported at ₹53.80 crore, up 22.64% from ₹43.87 crore in December 2024. Employee cost was ₹157.80 crore in December 2025 versus ₹166.70 crore in December 2024, while other expenses were reported at ₹162.40 crore compared with ₹40.55 crore a year earlier. The same table shows an exceptional item of -₹4.80 crore in December 2025 and basic EPS of ₹19.53.

FY26 commentary cited: other income and profit volatility

The provided text also flags concerns about profit volatility linked to other income movements. It states that net profit declined 2.78% quarter-on-quarter to ₹80.30 crore, primarily due to a 26.47% drop in other income from ₹20.40 crore to ₹15.00 crore. It adds that other income has ranged from ₹6.20 crore to ₹20.40 crore over seven quarters, suggesting volatility that can distort bottom-line comparisons. The text also notes PAT margin compression to 13.86% from 14.56% in Q2 FY26, and that operating margins expanded to their highest level in seven quarters even as net profit softened. This framing matters because it separates core operating performance from non-operating line items.

Timeline of disclosed board dates

Cigniti has disclosed multiple board meeting dates for periodic results in recent quarters. It informed that a board meeting was scheduled for October 24, 2025 to review Q2 and H1 FY2026 results. It also announced a board meeting on January 22, 2026 to approve Q3 results. Separately, the data includes a disclosure that the company had informed BSE of a meeting scheduled on May 5, 2025 to consider and approve audited results for the quarter and year ended March 31, 2025. These dated disclosures help investors track how quickly results are typically finalised and released after quarter-end.

Market impact: what investors may focus on

The May 5, 2026 results meeting is likely to be tracked for three factual threads already present in the public narrative. First is the company’s growth trajectory, given the strong reported YoY expansion in standalone December-quarter sales and the reported FY2025 revenue growth. Second is profit quality, because the text specifically highlights that changes in other income can materially swing net profit and PAT margins. Third is the corporate structure context after Coforge’s reported 54% stake acquisition and the board-approved merger, which can influence how investors interpret consolidated reporting, disclosures, and any exceptional items. The immediate market reaction, if any, will depend on what is released in the official filing and how it reconciles the different performance summaries circulating in reports.

Conclusion

Cigniti Technologies’ May 5, 2026 board meeting for Q4 FY26 results sets a clear near-term catalyst for the stock. Recent reported data points include strong standalone sales growth for the December 2025 quarter, alongside commentary pointing to profit sensitivity to other income. Investors will look to the company’s exchange filing for the final numbers, comparable-period definitions, and any updates related to the Coforge merger approval and ownership changes. The next concrete step is the board’s consideration of Q4 FY26 results on the scheduled date, followed by the formal results announcement.